KK
ALNY icon

KLP Kapitalforvaltning’s Alnylam Pharmaceuticals ALNY Stock Holding History

KLP Kapitalforvaltning’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
56,760
+5,560
+11% +$1.68M 0.06% 293
2026
Q1 		$16.9M Buy
51,200
+760
+2% +$259K 0.07% 271
2025
Q4 		$20.1M Buy
50,440
+1,640
+3% +$726K 0.08% 239
2025
Q3 		$22.3M Sell
48,800
-300
-0.6% -$122K 0.09% 216
2025
Q2 		$16M Buy
49,100
+5,400
+12% +$1.49M 0.07% 261
2025
Q1 		$11.8M Hold
43,700
– – 0.06% 310
2024
Q4 		$10.3M Buy
+43,700
New +$11.5M 0.05% 338

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's ALNY Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Alnylam Pharmaceuticals (ALNY) stake by 11% in Q2 2026, buying an estimated $1.68M and bringing the position to 56,760 shares worth $17.1M. The position accounts for 0.06% of the portfolio, ranked #293.

KLP Kapitalforvaltning first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.3M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • KLP Kapitalforvaltning held 56,760 shares of Alnylam Pharmaceuticals worth $17.1M as of Q2 2026.
  • KLP Kapitalforvaltning bought 5,560 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
  • Alnylam Pharmaceuticals made up 0.06% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #293 holding.
  • KLP Kapitalforvaltning first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Alnylam Pharmaceuticals position peaked at $22.3M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.